סיגניפור לאר 40 מ"ג - Signifor lar 40 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× |
| ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | H01CB Somatostatin and analogues | ||||||||||||||||||||||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||||||||
| צ×רת ××ª× | ת××-שר××¨× - I.M | ||||||||||||||||||||||||
| צ×רת ××× ×× | ×××§× ×××ס ×××× ×ª תר×××£ ×××רק×, POWDER AND SOLVENT FOR SUSPENSION FOR INJECTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||||||||
| ×ת×××× | Signifor LAR is indicated for the treatment of adult patients with acromegaly for whom surgery is not an option or has not been curative and who are inadequately controlled on treatment with another somatostatin analogue. | ||||||||||||||||||||||||
| |||||||||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | ||||||||||||||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ס××× ×פ×ר ××ר 40 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | RECORDATI RARE DISEASES, FRANCE |
| ×©× ××¢× ×ר×ש×× | MEDISON PHARMA LTD |
| ר×ש××× | ת×ר×× ××ש×: 10/2014. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | 19/06/2024 |
ת××× ×ª ×ר×××
השינוי האחרון נעשה בֹ־19 ביוני 2024 ב־05:26